Digital brain health solutions company Cambridge Cognition said it had won a two-year contract worth £750,000 to provide cognitive tests and electronic clinical outcome assessments for an Alzheimer's trial. The company said it expected to receive a 'considerable proportion' of the revenue in 2021. 'To deliver the Contract, Cambridge Cognition will configure existing modules developed for previous clinical trials rather than undertaking bespoke software development,' it added.
-0.50p (-0.93%)delayed 16:57PM
Sign up to our
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
UK 350 Risers and Fallers
Tweets not available.